Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Women citizens' association.

The Eugenics review·2011

Same author

Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial (1).

Journal of glaucoma·2009

Same author

Synthesis of available data.

Journal of glaucoma·2009

Same author

Chronic uveitis and glaucoma.

Journal of glaucoma·2009

Same author

The ocular hypertension treatment study.

Journal of glaucoma·2009

Same author

Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS).

Ophthalmology·2001

Same journal

Tonographic outflow facility and intraocular pressure after standalone OMNI surgery.

Journal of glaucoma·2026

Same journal

Factors Associated With Retinal Nerve Fiber Layer Asymmetry in Primary Open-Angle Glaucoma Among Individuals of African Ancestry.

Journal of glaucoma·2026

Same journal

Haploinsufficiency of PITX2 in Four Chinese Families with Axenfeld-Rieger Syndrome.

Journal of glaucoma·2026

Same journal

Intraocular Pressure-Lowering Effect of Omidenepag Isopropyl as a Predictor for the Efficacy of Laser Trabeculoplasty.

Journal of glaucoma·2026

Same journal

Comparative Outcomes Between Micropulse and Slow-Coagulation Transscleral Cyclophotocoagulation in Eyes With Good Visual Acuity.

Journal of glaucoma·2026

Same journal

Machine Learning With Optical Coherence Tomography for Glaucoma Diagnosis.

Journal of glaucoma·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Ocular hypertension treatment study: design issues.

M O Gordon¹, M A Kass

¹Dr. M. O. Gordon at Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, Medical School Box 8096, 660 South Euclid Ave., St. Louis, MO 63110, U.S.A.

Journal of Glaucoma

|November 19, 2009

Summary

This summary is machine-generated.

Planning is underway for a large clinical trial investigating ocular hypertension treatments. Patient enrollment for this multicenter study begins in January 1994.

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

Related Experiment Videos

Last Updated: Jun 18, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

Area of Science:

Ophthalmology
Clinical Trials
Public Health

Background:

Ocular hypertension is a significant risk factor for glaucoma.
Effective treatment strategies are crucial for preventing vision loss.
Large-scale trials are needed to evaluate treatment efficacy and safety.

Purpose of the Study:

To outline the design and conduct considerations for a major clinical trial.
To establish a framework for a multicenter study on ocular hypertension treatment.
To prepare for patient enrollment commencing January 1994.

Main Methods:

The report details the planning phase of a large, multicenter clinical trial.
Considerations for trial design and conduct are discussed.
The study focuses on the treatment of ocular hypertension.

Main Results:

The trial design and conduct considerations have been established.
The study is prepared to commence patient enrollment.
Key logistical and ethical aspects have been addressed.

Conclusions:

A robust plan is in place for a significant clinical trial.
The study aims to advance the understanding and treatment of ocular hypertension.
The trial's commencement is scheduled for January 1994.